Physician profile
Daniel J Buckley
NPI 1013916733
$1,102.12
in general payments reported to CMS, 2019-2025
19 companies · $451 in 2025
The $451 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $99.67 · 2020: $76.03 · 2021: $18.40 · 2022: $102 · 2023: $75.72 · 2024: $280 · 2025: $451.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $806.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $806.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $182.52 | 2022-2025 | Miebo, Xiidra, Vyzulta |
| Alcon Vision LLC | $148.49 | 2022-2025 | Rocklatan, Hydrus Microstent |
| Oyster Point Pharma, INC. | $127.94 | 2023-2025 | Tyrvaya, Ryzumvi, Ryzumvi |
| Amgen INC. | $110.65 | 2024-2025 | Tepezza |
| Allergan, INC. | $76.61 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $74.84 | 2024-2025 | Xdemvy |
| Abbvie INC. | $50.28 | 2024-2025 | |
| Harrow Eye, LLC | $45.01 | 2025 | Vevye |
| Sun Pharmaceutical Industries INC. | $41.46 | 2019-2021 | |
| Thea Pharma INC. | $36.70 | 2023-2025 | Iyuzeh |
| Aerie Pharmaceuticals, INC. | $34.54 | 2020 | |
| Astellas Pharma US INC | $31.94 | 2025 | Izervay |
| Novartis Pharmaceuticals Corporation | $24.72 | 2022 | |
| Sight Sciences, INC. | $23.63 | 2023 | Tearcare System |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $23.23 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dompe US, INC. | $19.54 | 2025 | Oxervate |
| Eyevance Pharmaceuticals LLC | $18.26 | 2020 | |
| Rxsight INC | $16.02 | 2023 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Injector Cartridge |
| Mallinckrodt Hospital Products INC. | $15.74 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Buckley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.